UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Improving outcomes for amputees: The health-related quality of life and cost utility analysis of osseointegration prosthetics in transfemoral amputees

Injury, 2022-12, Vol.53 (12), p.4114-4122

2022

Volltextzugriff (PDF)

Military trauma and orthopaedics experience of the UK COVID-19 pandemic: a lesson in versatility and how it can influence our deployed role

BMJ military health, 2023-05, Vol.169 (e1), p.e71-e73

2023

Volltextzugriff (PDF)

A human monoclonal antibody 264RAD targeting αvβ6 integrin reduces tumour growth and metastasis, and modulates key biomarkers in vivo

Oncogene, 2013-09, Vol.32 (37), p.4406-4416

2013

Volltextzugriff (PDF)

A human monoclonal antibody 264RAD targeting alpha v beta 6 integrin reduces tumour growth and metastasis, and modulates key biomarkers in vivo

Oncogene, 2013-09, Vol.32 (37), p.4406-4416

2013

Volltextzugriff (PDF)

The UK defence anaesthesia experience with the Zambia Anaesthesia Development Programme: a surgical response

BMJ military health, 2021-08, Vol.167 (4), p.289-289

2021

Volltextzugriff (PDF)

Long-term follow-up of two patients with retained intraosseous sternal needles

Journal of the Royal Army Medical Corps, 2017-06, Vol.163 (3), p.221-222

2017

Volltextzugriff (PDF)

The open blast pelvis: The significant burden of management

Injury extra, 2012-10, Vol.43 (10), p.87-87

2012

Volltextzugriff (PDF)

The open blast pelvis: The significant burden of management

Injury, 2012-10, Vol.43 (10), p.1624-1624

2012

Volltextzugriff (PDF)

Use of dynamic contrast-enhanced MRI to evaluate acute treatment with ZD6474, a VEGF signalling inhibitor, in PC-3 prostate tumours

British journal of cancer, 2003-11, Vol.89 (10), p.1889-1895

2003

Volltextzugriff (PDF)

O-112 Jean Purdy - The silent partner

Human reproduction (Oxford), 2023-06, Vol.38 (Supplement_1)

Kendrew, H J

2023

Volltextzugriff (PDF)

Effects of AZD2171 and vandetanib (ZD6474, Zactima) on haemodynamic variables in an SW620 human colon tumour model: an investigation using dynamic contrast-enhanced MRI and the rapid clearance blood pool contrast agent, P792 (gadomelitol)

NMR in biomedicine, 2008-01, Vol.21 (1), p.42-52

2008

Volltextzugriff (PDF)

Periprosthetic osseointegration fractures are infrequent and management is familiar

The bone & joint journal, 2020-02, Vol.102-B (2), p.162-169

2020

Volltextzugriff (PDF)

The angiogenic receptor KDR is widely distributed in human tissues and tumours and relocates intracellularly on phosphorylation. An immunohistochemical study

Histopathology, 2003-07, Vol.43 (1), p.33-39

2003

Volltextzugriff (PDF)

Discovery and functional characterization of potent, balanced AXL/ MER inhibitors using a novel MER X-Ray crystal structure

European journal of cancer (1990), 2022-10, Vol.174, p.S19-S19

2022

Volltextzugriff (PDF)

ZM323881, a Novel Inhibitor of Vascular Endothelial Growth Factor-Receptor-2 Tyrosine Kinase Activity

Microcirculation (New York, N.Y. 1994), 2002-12, Vol.9 (6), p.513-522

2002

Volltextzugriff (PDF)

Encyclopedia of molecular biology

1994

Volltextzugriff (PDF)

ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration

Cancer research (Chicago, Ill.), 2002-08, Vol.62 (16), p.4645-4655

2002

Volltextzugriff (PDF)

Minimal contribution of desmethyl-gefitinib, the major human plasma metabolite of gefitinib, to epidermal growth factor receptor (EGFR)-mediated tumour growth inhibition

Xenobiotica, 2006-01, Vol.36 (1), p.29-39

2006

Volltextzugriff (PDF)

Bionic Man? A Systematic Review of Osseointegrated Implants Following Major Lower Limb Amputation

International journal of surgery (London, England), 2017-11, Vol.47, p.S83-S84

2017

Volltextzugriff (PDF)

ZD6474, a potent inhibitor of Vascular endothelial growth factor signaling, combined with radiotherapy: Schedule-dependent enhancement of antitumor activity

Clinical cancer research, 2004-12, Vol.10 (24), p.8587-8593

2004

Volltextzugriff (PDF)

Novel 4-Anilinoquinazolines with C-7 Basic Side Chains: Design and Structure Activity Relationship of a Series of Potent, Orally Active, VEGF Receptor Tyrosine Kinase Inhibitors

Journal of medicinal chemistry, 2002-03, Vol.45 (6), p.1300-1312

2002

Volltextzugriff (PDF)

238 Tumor penetration of therapeutic antibodies

European journal of cancer supplements, 2010, Vol.8 (7), p.77-77

2010

Volltextzugriff (PDF)

Modern military surgery: lessons from Iraq and Afghanistan

Journal of bone and joint surgery. British volume, 2012-04, Vol.94 (4), p.536-543

2012

Volltextzugriff (PDF)

Tumor penetration of gefitinib (Iressa), an epidermal growth factor receptor tyrosine kinase inhibitor

Molecular cancer therapeutics, 2005-04, Vol.4 (4), p.641-649

2005

Volltextzugriff (PDF)

Design and Structure−Activity Relationship of a New Class of Potent VEGF Receptor Tyrosine Kinase Inhibitors

Journal of medicinal chemistry, 1999-12, Vol.42 (26), p.5369-5389

1999

Volltextzugriff (PDF)

1 – 25 von 267

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(239)
Mit Volltextzugriff
(224)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(157)
Life Sciences & Biomedicine
(74)
Physical Sciences
(53)
Animals
(38)
Humans
(38)
Multidisciplinary Sciences
(34)
Science & Technology - Other Topics
(34)
Astronomy & Astrophysics
(31)
Biological And Medical Sciences
(21)
Chemistry
(21)
Old Medline
(21)
Mice
(20)
Female
(19)
Physics
(19)
Astrophysics
(18)
Biochemistry & Molecular Biology
(17)
Male
(15)
Medical Sciences
(14)
Myoglobin
(14)
Quinazolines - Pharmacology
(14)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Improving outcomes for amputees: The health-related quality of life and cost utility analysis of osseointegration prosthetics in transfemoral amputees

Military trauma and orthopaedics experience of the UK COVID-19 pandemic: a lesson in versatility and how it can influence our deployed role

A human monoclonal antibody 264RAD targeting αvβ6 integrin reduces tumour growth and metastasis, and modulates key biomarkers in vivo

A human monoclonal antibody 264RAD targeting alpha v beta 6 integrin reduces tumour growth and metastasis, and modulates key biomarkers in vivo

The UK defence anaesthesia experience with the Zambia Anaesthesia Development Programme: a surgical response

Long-term follow-up of two patients with retained intraosseous sternal needles

The open blast pelvis: The significant burden of management

The open blast pelvis: The significant burden of management

Use of dynamic contrast-enhanced MRI to evaluate acute treatment with ZD6474, a VEGF signalling inhibitor, in PC-3 prostate tumours

O-112 Jean Purdy - The silent partner

Effects of AZD2171 and vandetanib (ZD6474, Zactima) on haemodynamic variables in an SW620 human colon tumour model: an investigation using dynamic contrast-enhanced MRI and the rapid clearance blood pool contrast agent, P792 (gadomelitol)

Periprosthetic osseointegration fractures are infrequent and management is familiar

The angiogenic receptor KDR is widely distributed in human tissues and tumours and relocates intracellularly on phosphorylation. An immunohistochemical study

Discovery and functional characterization of potent, balanced AXL/ MER inhibitors using a novel MER X-Ray crystal structure

ZM323881, a Novel Inhibitor of Vascular Endothelial Growth Factor-Receptor-2 Tyrosine Kinase Activity

Encyclopedia of molecular biology

ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration

Minimal contribution of desmethyl-gefitinib, the major human plasma metabolite of gefitinib, to epidermal growth factor receptor (EGFR)-mediated tumour growth inhibition

Bionic Man? A Systematic Review of Osseointegrated Implants Following Major Lower Limb Amputation

ZD6474, a potent inhibitor of Vascular endothelial growth factor signaling, combined with radiotherapy: Schedule-dependent enhancement of antitumor activity

Novel 4-Anilinoquinazolines with C-7 Basic Side Chains: Design and Structure Activity Relationship of a Series of Potent, Orally Active, VEGF Receptor Tyrosine Kinase Inhibitors

238 Tumor penetration of therapeutic antibodies

Modern military surgery: lessons from Iraq and Afghanistan

Tumor penetration of gefitinib (Iressa), an epidermal growth factor receptor tyrosine kinase inhibitor

Design and Structure−Activity Relationship of a New Class of Potent VEGF Receptor Tyrosine Kinase Inhibitors

Aktive Filter

Suchergebnisse filtern